PACK is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is weak technically, there is no supportive news catalyst, no positive proprietary trading signal, and sentiment from options/market participants is not strong enough to justify an immediate entry. Based on the current data, the clearer decision is to stay out rather than buy now.
The technical picture is bearish to weak. The stock closed at 6.55 after a -5.21% regular market move, which shows immediate downside pressure. MACD histogram is -0.13 and negatively expanding, confirming deteriorating momentum. RSI_6 at 27.635 is near oversold territory but not yet a clean reversal signal. Moving averages are converging, which usually means the trend is undecided, but the price is trading below the pivot at 7.165 and below R1 at 7.662, with nearby support at 6.669 and deeper support at 6.362. The short-term pattern data also implies limited upside, with a 60% chance of -0.49% next day and only modest gains expected over the next week and month.

["Options open interest is more call-heavy than put-heavy, which is a mild bullish sentiment sign.", "RSI is near oversold levels, which could support a short-term bounce if buyers step in.", "Support is nearby around 6.669 and 6.362, which may help limit downside in the short run."]
["No news in the recent week, so there is no event-driven catalyst to support a rebound.", "MACD momentum is negative and worsening, indicating ongoing technical weakness.", "The stock fell 5.21% on the latest session, showing clear near-term selling pressure.", "No AI Stock Picker signal today.", "No SwingMax signal recently.", "Hedge funds are neutral with no significant trading trend.", "Insiders are neutral with no significant trading trend.", "No recent congress trading data is available.", "Price is below the pivot level, which keeps the stock technically fragile."]
No usable latest-quarter financial snapshot was provided because the financial data returned an error. Since the latest quarter figures are unavailable, there is no confirmed evidence here of accelerating revenue, margin improvement, or earnings growth to support a long-term buy decision. The latest quarter season cannot be identified from the provided data.
No analyst rating or price target trend data was provided, so there is no evidence of a favorable Wall Street revision cycle. In the absence of upgrades or rising targets, the Wall Street view appears neutral rather than constructive. Pros are limited to mild options positioning and possible oversold conditions, while the cons are weaker price action, no catalysts, and no visible support from analysts.